New program aims to keep hospital patients on track for opioid and meth recovery
NCT ID NCT06027814
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a program called MIAPP that adds a patient navigator, smartphone check-ins, and small rewards to usual care for people who start buprenorphine for opioid use in the hospital and also use methamphetamine. The goal is to help them connect to outpatient treatment within 30 days and stay on medication for 90 days. The study involves 40 adults and compares the new program to standard care alone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MEDICATION ADHERENCE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Harborview Medical Center
Seattle, Washington, 98104, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new tool better measure opioid withdrawal?
- Giving patients a voice in methadone care: a new approach under the microscope
- Can a sleep pill boost success in opioid treatment?
- Can a smartphone app help people stick to their meds?
- Can coaching clinics curb HIV? a new strategy puts it to the test
- Could a trip to the pediatrician help teens beat opioid addiction?